These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience. Yildiran Keskin GS; Erturk I; Aykan MB; Acar R; Dumludag A; Topal A; Koseoglu C; Kuzu OF; Ornek E; Karadurmus N Oncol Res Treat; 2024; 47(6):262-272. PubMed ID: 38583428 [TBL] [Abstract][Full Text] [Related]
5. A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study. Selle F; Wittnebel S; Biron P; Gravis G; Roubaud G; Bui BN; Delva R; Bay JO; Fléchon A; Geoffrois L; Caty A; Soares DG; de Revel T; Fizazi K; Gligorov J; Micléa JM; Dubot C; Provent S; Temby I; Gaulet M; Horn E; Brindel I; Lotz JP Ann Oncol; 2014 Sep; 25(9):1775-1782. PubMed ID: 24894084 [TBL] [Abstract][Full Text] [Related]
6. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor? Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372 [TBL] [Abstract][Full Text] [Related]
7. Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors. Nieto Y; Tu SM; Bassett R; Jones RB; Gulbis AM; Tannir N; Kingham A; Ledesma C; Margolin K; Holmberg L; Champlin R; Pagliaro L Ann Oncol; 2015 Oct; 26(10):2125-32. PubMed ID: 26199392 [TBL] [Abstract][Full Text] [Related]
8. Stable hematopoietic recovery after peripheral blood stem cell transplantation in patients receiving high-dose chemotherapy for advanced germ cell tumors. Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M Anticancer Res; 2006; 26(6C):4965-8. PubMed ID: 17214371 [TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases. Kalra M; Adra N; Hanna N; Abonour R; Einhorn LH Cancer; 2020 Mar; 126(6):1202-1207. PubMed ID: 31743434 [TBL] [Abstract][Full Text] [Related]
12. Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation. Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N Cancer; 2021 Oct; 127(20):3751-3760. PubMed ID: 34260067 [TBL] [Abstract][Full Text] [Related]
13. Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. Rick O; Bokemeyer C; Beyer J; Hartmann JT; Schwella N; Kingreen D; Neureither S; Metzner B; Casper J; Wandt H; Hartmann F; Schmoll HJ; Derigs G; Gerl A; Berdel WE; Kanz L; Siegert W J Clin Oncol; 2001 Jan; 19(1):81-8. PubMed ID: 11134198 [TBL] [Abstract][Full Text] [Related]
14. Long-term survival after high-dose salvage chemotherapy for germ cell malignancies with adverse prognostic variables. Vaena DA; Abonour R; Einhorn LH J Clin Oncol; 2003 Nov; 21(22):4100-4. PubMed ID: 14615439 [TBL] [Abstract][Full Text] [Related]
15. Salvage chemotherapy with high-dose carboplatin plus etoposide and autologous peripheral blood stem cell transplant in male pure choriocarcinoma: a retrospective analysis of 13 cases. Papiani G; Einhorn LH Bone Marrow Transplant; 2007 Aug; 40(3):235-7. PubMed ID: 17563738 [TBL] [Abstract][Full Text] [Related]
16. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Beyer J; Kingreen D; Krause M; Schleicher J; Schwaner I; Schwella N; Huhn D; Siegert W Cancer; 1997 Jan; 79(1):161-8. PubMed ID: 8988741 [TBL] [Abstract][Full Text] [Related]
17. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors. Lorch A; Neubauer A; Hackenthal M; Dieing A; Hartmann JT; Rick O; Bokemeyer C; Beyer J Ann Oncol; 2010 Apr; 21(4):820-825. PubMed ID: 19822531 [TBL] [Abstract][Full Text] [Related]
18. Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumors. Motzer RJ; Gulati SC; Tong WP; Menendez-Botet C; Lyn P; Mazumdar M; Vlamis V; Lin S; Bosl GJ Cancer Res; 1993 Aug; 53(16):3730-5. PubMed ID: 8393380 [TBL] [Abstract][Full Text] [Related]
19. Outcomes of combined modality therapy for patients with stage III or IV mediastinal malignant germ cell tumors. Kuwano H; Tsuchiya T; Murayama T; Sano A; Nagayama K; Yoshida Y; Murakawa T; Nakajima J Surg Today; 2014 Mar; 44(3):499-504. PubMed ID: 23553421 [TBL] [Abstract][Full Text] [Related]
20. First-line high-dose chemotherapy combined with peripheral blood stem cell transplantation for patients with advanced extragonadal germ cell tumors. Kumano M; Miyake H; Hara I; Furukawa J; Takenaka A; Fujisawa M Int J Urol; 2007 Apr; 14(4):336-8. PubMed ID: 17470166 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]